Skip to main content
Top
Published in: Current Treatment Options in Oncology 1/2020

Open Access 01-01-2020 | Care | Palliative and Supportive Care (MP Davis, Section Editor)

Prognosticating for Adult Patients With Advanced Incurable Cancer: a Needed Oncologist Skill

Authors: Christina Chu, BMedSci, MBChB, MRCP, Rebecca Anderson, MSc, Nicola White, PhD, Patrick Stone, MA, MD, FRCP

Published in: Current Treatment Options in Oncology | Issue 1/2020

Login to get access

Opinion statement

Patients with advanced cancer and their families commonly seek information about prognosis to aid decision-making in medical (e.g. surrounding treatment), psychological (e.g. saying goodbye), and social (e.g. getting affairs in order) domains. Oncologists therefore have a responsibility to identify and address these requests by formulating and sensitively communicating information about prognosis. Current evidence suggests that clinician predictions are correlated with actual survival but tend to be overestimations. In an attempt to cultivate prognostic skills, it is recommended that clinicians practice formulating and recording subjective estimates of prognosis in advanced cancer patient’s medical notes. When possible, a multi-professional prognostic estimate should be sought as these may be more accurate than individual predictions alone. Clinicians may consider auditing the accuracy of their predictions periodically and using feedback from this process to improve their prognostic skills.
Clinicians may also consider using validated prognostic tools to complement their clinical judgements. However, there is currently only limited evidence about the comparative accuracy of different prognostic tools or the extent to which these measures are superior to clinical judgement. Oncologists and palliative care physicians should ensure that they receive adequate training in advanced communication skills, which builds upon their pre-existing skills, to sensitively deliver information on prognosis. In particular, clinicians should acknowledge their own prognostic uncertainty and should emphasise the supportive care that can continue to be provided after stopping cancer-directed therapies.
Literature
3.
go back to reference Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284(19):2476–82.CrossRefPubMed Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284(19):2476–82.CrossRefPubMed
7.
go back to reference Christakis N. Death foretold: prophecy and prognosis in medical care. 1st ed. University of Chicago Press; 1999. Christakis N. Death foretold: prophecy and prognosis in medical care. 1st ed. University of Chicago Press; 1999.
13.
19.
go back to reference Royal College of General Practitioners. Matters of life and death: helping people to live well until they die. General practice guidance for implementing the RCGP/RCN end of life care patient charter; 2012. Royal College of General Practitioners. Matters of life and death: helping people to live well until they die. General practice guidance for implementing the RCGP/RCN end of life care patient charter; 2012.
33. •
48.
go back to reference White N, Oostendorp LJM, Tomlinson C, Yardley S, Ricciardi F, Gökalp H, Minton O, Boland JW, Clark B, Harries P and Stone P. Online training improves medical students’ ability to recognise when a person is dying: the ORaClES randomised controlled trial. Palliat Med in press. White N, Oostendorp LJM, Tomlinson C, Yardley S, Ricciardi F, Gökalp H, Minton O, Boland JW, Clark B, Harries P and Stone P. Online training improves medical students’ ability to recognise when a person is dying: the ORaClES randomised controlled trial. Palliat Med in press.
49.
go back to reference Eychmüller S, Benedetti FD, Latten R, Tal K, Walker J, Costantini M. ‘Diagnosing dying’ in cancer patients - a systematic literature review. Eur J Palliat Care. 2013;20(6):292–6. Eychmüller S, Benedetti FD, Latten R, Tal K, Walker J, Costantini M. ‘Diagnosing dying’ in cancer patients - a systematic literature review. Eur J Palliat Care. 2013;20(6):292–6.
54.
go back to reference Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press. p. 191–205. Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press. p. 191–205.
56.
go back to reference Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12(1):5–11.CrossRefPubMed Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12(1):5–11.CrossRefPubMed
61.
63.
go back to reference Morita T, Tsunoda J, Inoue S, Chihara S. The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7(3):128–33.CrossRefPubMed Morita T, Tsunoda J, Inoue S, Chihara S. The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7(3):128–33.CrossRefPubMed
68. ••
76.
go back to reference Witkamp FE, van Zuylen L, Vergouwe Y, Rijt, CCD, van der Heide A. Concordance between experiences of bereaved relatives, physicians, and nurses with hospital end-of-life care: everyone has their “Own Truth”. International Journal of Palliative Care. 2015 (Article ID 623890). Witkamp FE, van Zuylen L, Vergouwe Y, Rijt, CCD, van der Heide A. Concordance between experiences of bereaved relatives, physicians, and nurses with hospital end-of-life care: everyone has their “Own Truth”. International Journal of Palliative Care. 2015 (Article ID 623890).
77.
82.
go back to reference Clayton JM, Hancock KM, Butow PN, Tattersall MHN, Currow DC, Australian and New Zealand Expert Advisory Group, et al. Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust. 2007;186(12 Suppl):S77,-S9–83–108. Clayton JM, Hancock KM, Butow PN, Tattersall MHN, Currow DC, Australian and New Zealand Expert Advisory Group, et al. Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust. 2007;186(12 Suppl):S77,-S9–83–108.
83.
go back to reference National Institute of Health and Care Excellence. Care of dying adults in the last days of life [NG31]. NICE; 2015. National Institute of Health and Care Excellence. Care of dying adults in the last days of life [NG31]. NICE; 2015.
84. ••
go back to reference Royal College of Physicians. Talking about dying: how to begin honest conversations about what lies ahead: Royal College of Physicians; 2018. Evidence-based report providing clinicians clear information about barriers, common myths, recommendations, and further resources to help discussions with patients about their end-of-life care. Royal College of Physicians. Talking about dying: how to begin honest conversations about what lies ahead: Royal College of Physicians; 2018. Evidence-based report providing clinicians clear information about barriers, common myths, recommendations, and further resources to help discussions with patients about their end-of-life care.
87.
go back to reference Anderson R, Stone P, Low J, Bloch S. P01–098 Discussing prognosis and managing uncertainty in end-of-life conversations with family members: a conversation analytic study. European Association for Palliative Care; 2019. Berlin, Germany: Palliative Medicine. Anderson R, Stone P, Low J, Bloch S. P01–098 Discussing prognosis and managing uncertainty in end-of-life conversations with family members: a conversation analytic study. European Association for Palliative Care; 2019. Berlin, Germany: Palliative Medicine.
90. •
go back to reference Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M et al. Evaluating an intervention to improve communication between oncology clinicians and patients with life-limiting cancer: a cluster randomized clinical trial of the serious illness care program. JAMA Oncol 2019;5(6):801–809. doi:https://doi.org/10.1001/jamaoncol.2019.0292. Demonstrates the benefits of introducing a communication intervention across a whole institution using a robust study design.CrossRefPubMed Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M et al. Evaluating an intervention to improve communication between oncology clinicians and patients with life-limiting cancer: a cluster randomized clinical trial of the serious illness care program. JAMA Oncol 2019;5(6):801–809. doi:https://​doi.​org/​10.​1001/​jamaoncol.​2019.​0292. Demonstrates the benefits of introducing a communication intervention across a whole institution using a robust study design.CrossRefPubMed
Metadata
Title
Prognosticating for Adult Patients With Advanced Incurable Cancer: a Needed Oncologist Skill
Authors
Christina Chu, BMedSci, MBChB, MRCP
Rebecca Anderson, MSc
Nicola White, PhD
Patrick Stone, MA, MD, FRCP
Publication date
01-01-2020
Publisher
Springer US
Keyword
Care
Published in
Current Treatment Options in Oncology / Issue 1/2020
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI
https://doi.org/10.1007/s11864-019-0698-2

Other articles of this Issue 1/2020

Current Treatment Options in Oncology 1/2020 Go to the issue

Palliative and Supportive Care (MP Davis, Section Editor)

Chemotherapy-Induced Sarcopenia

Lower Gastrointestinal Cancers (AB Benson, Section Editor)

Opioids in Cancer Development, Progression and Metastasis: Focus on Colorectal Cancer

Lower Gastrointestinal Cancers (AB Benson, Section Editor)

Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine